US National Library of Medicine
National Institutes of Health – Apr 2005
Havarinasab S, Häggqvist B, Björn E, Pollard KM, Hultman P.
Department of Molecular and Clinical Medicine, Molecular and Immunological Pathology (AIR), Linköping University, SE-581 85 Linköping, Sweden.
The possible health effects of the organic mercury compound thimerosal (ethylmercurithiosalicylate), which is rapidly metabolized to ethylmercury (EtHg), have recently been much debated and the effect of this compound on the immune system is largely unknown. We therefore studied the effect of thimerosal by treating A.SW (H-2s) mice, susceptible to induction of autoimmunity by heavy metals, with 10 mg thimerosal/L drinking water (internal dose ca 590 microg Hg/kg body weight/day) for up to 30 days. The lymph node expression of IL-2 and IL-15 mRNA was increased after 2 days, and of IL-4 and IFN-gamma mRNA after 6 and 14 days. During the first 14 days treatment, the number of splenocytes, including T and B cells as well as Ig-secreting cells decreased. A strong immunostimulation superseded after 30 days treatment with increase in splenic weight, number of splenocytes including T and B cells and Ig-secreting cells, and Th2- as well as Th-1-dependent serum immunoglobulins. Antinucleolar antibodies (ANoA) targeting the 34-kDa nucleolar protein fibrillarin, and systemic immune-complex deposits developed. The H-2s strains SJL and B10.S also responded to thimerosal treatment with ANoA. The A.TL and B10.TL strain, sharing background genes with the A.SW and B10.S strain, respectively, but with a different H-2 haplotype (t1), did not develop ANoA, linking the susceptibility to H-2. Thimerosal-treated H-2s mice homozygous for the nu mutation (SJL-nu/nu), or lacking the T-cell co-stimulatory molecule CD28 (B10.S-CD28-/-), did not develop ANoA, which showed that the autoimmune response is T-cell dependent. Using H-2s strains with targeted mutations, we found that IFN-gamma and IL-6, but not IL-4, is important for induction of ANoA by thimerosal. The maximum added renal concentration of thimerosal (EtHg) and inorganic mercury occurred after 14 days treatment and was 81 microg Hg/g. EtHg made up 59% and inorganic mercury 41% of the renal mercury. In conclusion, the organic mercury compound thimerosal (EtHg) has initial immunosuppressive effects similar to those of MeHg. However, in contrast to MeHg, thimerosal treatment leads in genetically susceptible mice to a second phase with strong immunostimulation and autoimmunity, which is T-cell dependent, H-2 linked and may at least partly be due to the inorganic mercury derived from the metabolism of ethyl mercury.
Clemetson CA. Med Hypotheses. 2004
Department of Obstetrics and Gynecology, Tulane University School of Medicine, New Orleans, LA, USA. firstname.lastname@example.org
The findings of subdural hematoma and retinal hemorrhages in infants, without any documented history of major trauma, do not always indicate child abuse. A combination of ascorbate depletion and the injection of foreign proteins can cause a very high blood histamine level, leading to capillary fragility and venular bleeding. This can be prevented by the administration of vitamin C.
Published: 24 June 2015
Benjamin M. AlthouseEmail author and Samuel V. Scarpino
Affiliated with Santa Fe Institute
The recent increase in whooping cough incidence (primarily caused by Bordetella pertussis) presents a challenge to both public health practitioners and scientists trying to understand the mechanisms behind its resurgence. Three main hypotheses have been proposed to explain the resurgence: 1) waning of protective immunity from vaccination or natural infection over time, 2) evolution of B. pertussis to escape protective immunity, and 3) low vaccine coverage. Recent studies have suggested a fourth mechanism: asymptomatic transmission from individuals vaccinated with the currently used acellular B. pertussis vaccines.
Using wavelet analyses of B. pertussis incidence in the United States (US) and United Kingdom (UK) and a phylodynamic analysis of 36 clinical B. pertussis isolates from the US, we find evidence in support of asymptomatic transmission of B. pertussis. Next, we examine the clinical, public health, and epidemiological consequences of asymptomatic B. pertussis transmission using a mathematical model.
We find that: 1) the timing of changes in age-specific attack rates observed in the US and UK are consistent with asymptomatic transmission; 2) the phylodynamic analysis of the US sequences indicates more genetic diversity in the overall bacterial population than would be suggested by the observed number of infections, a pattern expected with asymptomatic transmission; 3) asymptomatic infections can bias assessments of vaccine efficacy based on observations of B. pertussis-free weeks; 4) asymptomatic transmission can account for the observed increase in B. pertussis incidence; and 5) vaccinating individuals in close contact with infants too young to receive the vaccine (“cocooning” unvaccinated children) may be ineffective.
Although a clear role for the previously suggested mechanisms still exists, asymptomatic transmission is the most parsimonious explanation for many of the observations surrounding the resurgence of B. pertussis in the US and UK. These results have important implications for B. pertussis vaccination policy and present a complicated scenario for achieving herd immunity and B. pertussis eradication.
These quarterly meetings include a report from the Department of Justice (DOJ) on cases settled for vaccine injuries and deaths as mandated by the National Vaccine Injury Compensation Program (NVICP).
The NVICP was started as a result of a law passed in 1986 that gave pharmaceutical companies total legal immunity from being sued due to injuries and deaths resulting from vaccines.
Drug manufacturers in the vaccine market can now create as many new vaccines as they desire, with no risk of being sued if their product causes injury or death.
This has resulted in a huge increase of vaccines entering the market, and the U.S. government, through the Centers for Disease Control (CDC), is the largest purchaser of these vaccines, spending in excess of $4 billion taxpayer dollars each year to purchase these vaccines.
If you or a family member is injured or dies from vaccines, you must sue the federal government in this special vaccine court. Many cases are litigated for years before a settlement is reached.
James Chestnut, DC – Dubious Method Used By CDC & Big Pharma to “Prove” Flu Vaccine Efficacy
Is the CDC a defacto pharmaceutical company with an over $4 billion incentive to protect Merck and its other Big Pharma suppliers of vaccines? Is there proof of collusion and fraud at the highest levels of the CDC administration, and top-down influence on the allied health practitioners who administer the flu vaccine in blind faith to an unwitting public? What follows is an interview conducted by Toni Bark, MD of “Vaccines Revealed” with James Chestnut, DC an Evidence-Based Wellness and Prevention Lifestyle Clinician. Register for free for the entire 9-part docu-series “Vaccines Revealed” at their website by the same name.
VAXXED TV – Vaccines injured my children #vaxxed #DidYouKnow #Praybig
My son has autism from vaccines #vaxxed #DidYouKnow #Praybig
Vaccines gave my son autism #vaxxed #Didyouknow #Praybig
I didn’t know vaccines could hurt my children #vaxxed #DidYouKnow #Praybig
I’m done vaccinating my children #Vaxxed #PrayBig #DidYouKnow
I now know the truth about vaccines #DidYouKnow #vaxxed #Praybig
My son has autism from vaccines #Vaxxed #PrayBig #DidYouKnow
I will never vaccinate again. #Vaxxed #PrayBig #DidYouKnow
Heavy Metal Toxicity
Anu says goodbye
Testimony by Phil Robertson from Duck Dynasty
1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:
Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.